Online citations, reference lists, and bibliographies.
← Back to Search

Five-Year Survival Rates For Patients (PTS) With Metastatic Melanoma (MM) Treated With Ipilimumab (IPI) In Phase II Trials

C. Lebbe, J.S. Weber, M. Maio, B. Neyns, K. Harmankaya, K. Chin, D. Opatt McDowell, L. Cykowski, M.B. McHenry, J.D. Wolchok

Cite This
Download PDF
Analyze on Scholarcy
Share